Trevor Bushell, Ph.D. - Publications

University of Strathclyde, Glasgow, Scotland, United Kingdom 

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Pytka K, Dawson N, Tossell K, Ungless MA, Plevin R, Brett RR, Bushell TJ. Mitogen-activated protein kinase phosphatase-2 deletion modifies ventral tegmental area function and connectivity and alters reward processing. The European Journal of Neuroscience. PMID 31989721 DOI: 10.1111/ejn.14688  0.309
2018 Ritchie L, Tate R, Chamberlain LH, Robertson G, Zagnoni M, Sposito T, Wray S, Wright JA, Bryant CE, Gay NJ, Bushell TJ. Toll-like receptor 3 activation impairs excitability and synaptic activity via TRIF signalling in immature rat and human neurons. Neuropharmacology. PMID 29505789 DOI: 10.1016/J.Neuropharm.2018.02.025  0.436
2017 MacKerron C, Robertson G, Zagnoni M, Bushell TJ. A Microfluidic Platform for the Characterisation of CNS Active Compounds. Scientific Reports. 7: 15692. PMID 29146949 DOI: 10.1038/s41598-017-15950-0  0.345
2017 Salaun C, Ritchie L, Greaves J, Bushell TJ, Chamberlain LH. The C-terminal domain of zDHHC2 contains distinct sorting signals that regulate intracellular localisation in neurons and neuroendocrine cells. Molecular and Cellular Neurosciences. PMID 28768144 DOI: 10.1016/j.mcn.2017.07.007  0.325
2017 Cain SM, Garcia E, Waheed Z, Jones KL, Bushell TJ, Snutch TP. GABAB Receptors Suppress Burst-Firing in Reticular Thalamic Neurons. Channels (Austin, Tex.). 0. PMID 28742985 DOI: 10.1080/19336950.2017.1358836  0.504
2016 Cunningham M, McIntosh K, Bushell T, Sloan G, Plevin R. Proteinase-activated receptors (PARs) as targets for antiplatelet therapy. Biochemical Society Transactions. 44: 606-12. PMID 27068977 DOI: 10.1042/Bst20150282  0.39
2016 Abdul Rahman NZ, Greenwood SM, Brett RR, Tossell K, Ungless MA, Plevin R, Bushell TJ. Mitogen-Activated Protein Kinase Phosphatase-2 Deletion Impairs Synaptic Plasticity and Hippocampal-Dependent Memory. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 2348-54. PMID 26911683 DOI: 10.1523/Jneurosci.3825-15.2016  0.688
2015 Bushell TJ, Cunningham MR, McIntosh KA, Moudio S, Plevin R. Proteinase-activated receptor 2: Are common functions in glial and immune cells linked to inflammation-related CNS disorders? Current Drug Targets. PMID 26648078  0.332
2014 Shrestha R, Shakya Shrestha S, Millingtona O, Brewer J, Bushell T. Immune responses in neurodegenerative diseases. Kathmandu University Medical Journal (Kumj). 12: 67-76. PMID 25219999 DOI: 10.3126/Kumj.V12I1.13646  0.449
2014 Robertson G, Bushell TJ, Zagnoni M. Chemically induced synaptic activity between mixed primary hippocampal co-cultures in a microfluidic system. Integrative Biology : Quantitative Biosciences From Nano to Macro. 6: 636-44. PMID 24796407 DOI: 10.1039/c3ib40221e  0.346
2014 Shrestha R, Millington O, Brewer J, Dev KK, Bushell TJ. Lymphocyte-mediated neuroprotection in in vitro models of excitotoxicity involves astrocytic activation and the inhibition of MAP kinase signalling pathways. Neuropharmacology. 76: 184-93. PMID 23831681 DOI: 10.1016/J.Neuropharm.2013.06.025  0.525
2013 Shrestha R, Millington O, Brewer J, Bushell T. Lymphocytes protect cortical neurons against excitotoxicity mediated by kainic acid, an in vitro model for neurodegeneration. Kathmandu University Medical Journal (Kumj). 11: 132-8. PMID 24096220 DOI: 10.3126/Kumj.V11I2.12488  0.54
2013 Shrestha R, Millington O, Brewer J, Bushell T. Is central nervous system an immune-privileged site? Kathmandu University Medical Journal (Kumj). 11: 102-7. PMID 23774427 DOI: 10.3126/Kumj.V11I1.11055  0.449
2011 Gan J, Greenwood SM, Cobb SR, Bushell TJ. Indirect modulation of neuronal excitability and synaptic transmission in the hippocampus by activation of proteinase-activated receptor-2. British Journal of Pharmacology. 163: 984-94. PMID 21366553 DOI: 10.1111/J.1476-5381.2011.01293.X  0.729
2011 Ledgerwood CJ, Greenwood SM, Brett RR, Pratt JA, Bushell TJ. Cannabidiol inhibits synaptic transmission in rat hippocampal cultures and slices via multiple receptor pathways. British Journal of Pharmacology. 162: 286-94. PMID 20825410 DOI: 10.1111/J.1476-5381.2010.01015.X  0.714
2010 Greenwood SM, Bushell TJ. Astrocytic activation and an inhibition of MAP kinases are required for proteinase-activated receptor-2-mediated protection from neurotoxicity. Journal of Neurochemistry. 113: 1471-80. PMID 20402964 DOI: 10.1111/J.1471-4159.2010.06737.X  0.693
2010 Pytka K, Librowski T, Filipek B, Paul A, Bushell T. Does receptor activation initiate the NFκB pathway in hippocampal neurones? Pharmacological Reports. 62: 59. DOI: 10.1016/S1734-1140(10)71163-4  0.414
2008 Cain SM, Meadows HJ, Dunlop J, Bushell TJ. mGlu4 potentiation of K(2P)2.1 is dependant on C-terminal dephosphorylation. Molecular and Cellular Neurosciences. 37: 32-9. PMID 17916432 DOI: 10.1016/j.mcn.2007.08.009  0.472
2007 Bushell T. The emergence of proteinase-activated receptor-2 as a novel target for the treatment of inflammation-related CNS disorders. The Journal of Physiology. 581: 7-16. PMID 17347265 DOI: 10.1113/Jphysiol.2007.129577  0.342
2006 Bushell TJ, Plevin R, Cobb S, Irving AJ. Characterization of proteinase-activated receptor 2 signalling and expression in rat hippocampal neurons and astrocytes. Neuropharmacology. 50: 714-25. PMID 16430928 DOI: 10.1016/j.neuropharm.2005.11.024  0.561
2002 Bushell TJ, Sansig G, Collett VJ, van der Putten H, Collingridge GL. Altered short-term synaptic plasticity in mice lacking the metabotropic glutamate receptor mGlu7. Thescientificworldjournal. 2: 730-7. PMID 12805997 DOI: 10.1100/tsw.2002.146  0.582
2002 Bushell T, Endoh T, Simen AA, Ren D, Bindokas VP, Miller RJ. Molecular components of tolerance to opiates in single hippocampal neurons. Molecular Pharmacology. 61: 55-64. PMID 11752206 DOI: 10.1124/Mol.61.1.55  0.396
2001 Sansig G, Bushell TJ, Clarke VR, Rozov A, Burnashev N, Portet C, Gasparini F, Schmutz M, Klebs K, Shigemoto R, Flor PJ, Kuhn R, Knoepfel T, Schroeder M, Hampson DR, et al. Increased seizure susceptibility in mice lacking metabotropic glutamate receptor 7. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 21: 8734-45. PMID 11698585 DOI: 10.1523/Jneurosci.21-22-08734.2001  0.541
1999 Bushell TJ, Lee CC, Shigemoto R, Miller RJ. Modulation of synaptic transmission and differential localisation of mGlus in cultured hippocampal autapses. Neuropharmacology. 38: 1553-67. PMID 10530817 DOI: 10.1016/S0028-3908(99)00103-3  0.389
1998 Meucci O, Fatatis A, Simen AA, Bushell TJ, Gray PW, Miller RJ. Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 95: 14500-5. PMID 9826729 DOI: 10.1073/Pnas.95.24.14500  0.347
1997 Isaac JTR, Luthi A, Bushell T, Kitjohn S, Palmer M, Ben B. Hippocampal ltp and ltd: mechanisms of induction and expression Faseb Journal. 11: A1285.  0.561
1996 Bushell TJ, Jane DE, Tse HW, Watkins JC, Garthwaite J, Collingridge GL. Pharmacological antagonism of the actions of group II and III mGluR agonists in the lateral perforant path of rat hippocampal slices. British Journal of Pharmacology. 117: 1457-62. PMID 8730739 DOI: 10.1111/J.1476-5381.1996.Tb15306.X  0.495
1996 Bushell T, Sansig G, Shigemoto R, Flor P, Kuhn R, Knoepfel T, Schroeder M, Collett V, Collingridge G, van der Putten H. An impairment of hippocampal synaptic plasticity in mice lacking mGlu7 receptors Neuropharmacology. 35: A6. DOI: 10.1016/0028-3908(96)84669-7  0.562
1995 Bushell TJ, Jane DE, Tse HW, Watkins JC, Davies CH, Garthwaite J, Collingridge GL. Antagonism of the synaptic depressant actions of L-AP4 in the lateral perforant path by MAP4. Neuropharmacology. 34: 239-41. PMID 7617150 DOI: 10.1016/0028-3908(95)00012-U  0.616
Show low-probability matches.